seffalair spiromax
teva b.v. - fluticasone propionate, salmeterol xinafoate - astma - legemidler for obstruktive sykdommer i luftveiene, - seffalair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.
singulair 5 mg
n.v. organon - kloosterstraat - montelukastnatrium - tyggetablett - 5 mg
singulair 4 mg
merck sharp & dohme b.v. - montelukastnatrium - granulat i dosepose - 4 mg
singulair 10 mg
n.v. organon - kloosterstraat - montelukastnatrium - tablett, filmdrasjert - 10 mg
singulair 4 mg
n.v. organon - kloosterstraat - montelukastnatrium - tyggetablett - 4 mg
singulair 10 mg
orifarm as - montelukastnatrium - tablett, filmdrasjert - 10 mg
singulair 10 mg
orifarm as - montelukastnatrium - tablett, filmdrasjert - 10 mg
singulair 4 mg
orifarm as - montelukastnatrium - tyggetablett - 4 mg
singulair 5 mg
orifarm as - montelukastnatrium - tyggetablett - 5 mg
singulair 10 mg
orifarm as - montelukastnatrium - tablett, filmdrasjert - 10 mg